For its fourth fiscal quarter (ending December 31), DENTSPLY SIRONA Inc (NASDAQ: XRAY) has reported E.P.S. of $0.32 compared to $-0.07 a year ago. This performance was $-0.12 short of the consensus estimate of $0.44. For the latest four quarters through December 31, E.P.S. were $-0.62 compared to $-4.41 a year ago.
Recent Price Action
DENTSPLY SIRONA Inc (NASDAQ: XRAY) stock closed at $32.68 on 2/29/24 after a modest decline of -1.9%. Moreover, unusually high trading volume at 154% of normal accompanied the decline. Relative to the market the stock has been weak over the last nine months and has declined -1.2% during the last week.
Current PriceTarget Research Rating
XRAY is expected to continue to be an important Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
DENTSPLY SIRONA has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing complementary signals. DENTSPLY SIRONA has a slightly negative Appreciation Score of 34 and a very low Power Rating of 15, and the Lowest Value Trend Rating results.
Rating Review
In light of this new information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment